title: Self-expanding wallstent endoprosthesis for malignant ureteral obstruction.
abstract: We present our experience with the self-expanding Wallstent endoprosthesis for ureteral recanalization in obstructive uropathy secondary to malignant pelvic disease. In total, 19 stents were inserted in 14 ureters. The follow-up included 100% of the patients. To date, except for one case, the patency of the stent has always persisted for the period of the survival of the patients, the longest ones being 4 and 4.1 years.
authors.affiliation: Department of Radiology, San Cecilio University Hospital, Faculty of Medicine, Granada, Spain.
authors.forename: E F
authors.initials: EF
authors.lastname: Díaz-Lucas
authors.forename: J L
authors.initials: JL
authors.lastname: Martínez-Torres
authors.forename: J
authors.initials: J
authors.lastname: Fernández Mena
authors.forename: O
authors.initials: O
authors.lastname: Carazo Martínez
authors.forename: A
authors.initials: A
authors.lastname: de la Fuente Serrano
authors.forename: A
authors.initials: A
authors.lastname: Zuluaga Gómez
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009403:Nephrostomy, Percutaneous / Q000295:instrumentation / Q000379:methods*; D010386:Pelvic Neoplasms / Q000150:complications* / Q000401:mortality; D019919:Prosthesis Implantation; D012189:Retrospective Studies; D015607:Stents; D015996:Survival Rate; D016896:Treatment Outcome; D014517:Ureteral Obstruction / Q000175:diagnosis / Q000209:etiology / Q000601:surgery*